Hauptkonkurrenten
Dividendenrendite (Y) Dividendenrendite (Y+1) KGV (Y) Price to Book (Y) EV / Sales (Y) Marktkap. / EBITDA (Y) Marktkap. / EBIT (Y) Kap.($)
- - - - - - - 11,38 Mio.
0,55 %0,61 %35.95x21.65x13.06x26.6x27.42x 1.097 Mrd.
2,06 %2,15 %27.63x6.96x6.35x17.27x19.08x 622 Mrd.
2,72 %2,84 %31.37x973.81x7.5x15.34x15.74x 449 Mrd.
2,96 %3,03 %18.05x6.7x4.48x11.03x12.44x 334 Mrd.
1,76 %1,86 %23.74x5.53x4.94x14.01x14.74x 294 Mrd.
2,83 %2,92 %21.75x6.51x5.59x13.5x14.78x 286 Mrd.
3,6 %3,5 %13.9x6.03x5.17x10.63x12.45x 213 Mrd.
2,8 %2,96 %23.5x17.9x6.26x11.01x14.32x 195 Mrd.
2,57 %2,63 %-45.11x8.01x5.46x30.35x60.97x 157 Mrd.
7,19 %7,16 %11.4x1.58x3.03x7.39x8.59x 139 Mrd.
-.--%-.--%28.57x5.73x8.75x19.72x20.53x 127 Mrd.
4,29 %4,41 %11.62x5.15x3.14x8.38x9.11x 120 Mrd.
3,54 %3,7 %12.54x4.58x2.76x8.09x9.14x 104 Mrd.
5,64 %5,97 %11.23x1.21x2.15x6.94x7.88x 103 Mrd.
1,8 %2,07 %24.5x5.55x8.32x15.74x16.46x 76,97 Mrd.
0,5 %1,37 %19.58x1.6x0.83x3.96x6.64x 7,18 Mrd.
3,95 %4,02 %42.08x1.11x2.61x9.58x26.53x 50,5 Mrd.
0,51 %0,58 %37.62x5.09x8.45x28.18x29.12x 51,46 Mrd.
Durchschnitt 2,74 % 2,88 % 19,44x 60,26x 5,49x 14,32x 18,11x 232,95 Mrd.
Gewichteter Durchschnitt nach Marktkapitalisierung 2,25 % 2,34 % 23,85x 108,51x 7,45x 17,38x 19,78x
Pharmazeutika - Andere